aidsnorthbay.com – AIDS Committee of North Bay & Area - To assist and support all persons infected or affected by HIV/AIDS and/or Hepatitis C and to limit the spread of the viruses through eduction, awareness and outreach strategies.

ZEPATIER™ (elbasvir/grazoprevir)

February 4th, 2016 at 9:00 am

February 4, 2016

Another new treatment for Hepatitis C has been approved in Canada. This medication is geared to Genotype 1, 3 and 4 in adults. Zepatier is currently not covered by Ontario Drug Benefit Program.

To read the article: www.newswire.ca/news-releases/merck-receives-approval-of-zepatier-elbasvirgrazoprevir-in-canada-for-the-treatment-of-chronic-hepatitis-c-for-patients-with-genotype-1-3-or-4-infection-following-priority-review-567492691.html

Please take to Keri or Kelsey for more information on this treatment.

%d bloggers like this: